The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
The natural history of chronic hepatitis B virus infection #
Open accessAbstract
Chronic hepatitis B virus (HBV) infection has a complicated course. Three phases are identified: an immune tolerant phase with high HBV DNA and normal alanine aminotransferase (ALT) levels associated with minimal liver disease; an immune active phase with high HBV DNA and elevated ALT levels with active liver inflammation; and an inactive phase with HBV DNA levels < 2000 IU/mL and normal ALT levels with minimal inflammation and fibrosis on liver biopsy. Affected persons can move progressively from one phase to the next and may revert backward. The primary adverse outcomes of chronic HBV infection are hepatocellular carcinoma (HCC) and cirrhosis. Published natural history studies were reviewed and ranked by the strength of evidence regarding the study design. Factors with the highest evidence of risk for development of HCC or cirrhosis from population-based prospective cohort studies include male sex, family history of HCC, HBV DNA level above 2000 IU/mL in persons above age 40, HBV genotypes C and F, and basal core promoter mutation. Those with the next highest level of evidence include aflatoxin exposure, and heavy alcohol and tobacco use. Improved methods to identify persons at highest risk of developing HCC or cirrhosis are needed to allow intervention earlier with antiviral therapy in appropriate patients. Future studies should include prospective follow-up of established population-based cohorts as well as new cohorts recruited from multiple centers stratified by HBV genotypes/subgenotypes and clinical phase to determine the incidence of the various HBV phases, HCC, and cirrhosis. Also, nested case-control studies assessing immunological and host genetic factors among persons with active and inactive disease phases, HCC, and cirrhosis could be conducted using these types of cohorts. (Hepatology 2009;49:S45–S55.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chen, C.-J. (2006) · JAMA · doi:10.1001/jama.295.1.65 · Cited by 3,140
Lavanchy, D. (2004) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00487.x · Cited by 2,642
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
Iloeje, U. H., Yang, H., Su, J., Jen, C., You, S., & Chen, C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.016 · Cited by 1,528
Hepatitis B virus.The major etiology of hepatocellular carcinoma
Beasley, R. P. (1988) · Cancer · doi:10.1002/1097-0142(19880515)61:10<1942::aid-cncr2820611003>3.0.co;2-j · Cited by 1,280
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Lu, S.-N., Liaw, Y.-F., You, S.-L., Sun, C.-A., Wang, L.-Y., Hsiao, C. K., Chen, P.-J., Chen, D.-S., & Chen, C.-J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013215 · Cited by 1,222
Mast, E. E., Weinbaum, C. M., Fiore, A. E., Alter, M. J., Bell, B. P., Finelli, L., Rodewald, L. E., Douglas, J. M., Janssen, R. S., & Ward, J. W. (2006) · PubMed · Cited by 1,132
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
Thio, C. L., Seaberg, E. C., Skolasky, R., Phair, J., Visscher, B., Muñoz, A., & Thomas, D. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11913-1 · Cited by 1,099
Norder, H., Couroucé, A.-M., Coursaget, P., Echevarria, J. M., Lee, S.-D., Mushahwar, I. K., Robertson, B. H., Locarnini, S., & Magnius, L. O. (2004) · Intervirology · doi:10.1159/000080872 · Cited by 868
Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B
Niederau, C., Heintges, T., Lange, S., Goldmann, G., Niederau, C. M., Mohr, L., & Häussinger, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342202 · Cited by 803
Management of hepatitis B: 2000—Summary of a workshop
Lok, A. S., Heathcote, E. J., & Hoofnagle, J. H. (2001) · Gastroenterology · doi:10.1053/gast.2001.24839 · Cited by 776
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
Hsu, Y.-S., Chien, R.-N., Yeh, C.-T., Sheen, I.-S., Chiou, H.-Y., Chu, C.-M., & Liaw, Y.-F. (2002) · Hepatology · doi:10.1053/jhep.2002.33638 · Cited by 705
Management of hepatitis B: Summary of a clinical research workshop†
Hoofnagle, J. H., Doo, E., Liang, T. J., Fleischer, R., & Lok, A. S. F. (2007) · Hepatology · doi:10.1002/hep.21627 · Cited by 628
Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Yeh, S.-H., Chen, P.-J., Iloeje, U. H., Jen, C.-L., Su, J., Wang, L.-Y., Lu, S.-N., You, S.-L., Chen, D.-S., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn243 · Cited by 580
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
Yu, M.-W., Yeh, S.-H., Chen, P.-J., Liaw, Y.-F., Lin, C.-L., Liu, C.-J., Shih, W.-L., Kao, J.-H., Chen, D.-S., & Chen, C.-J. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji043 · Cited by 569
Hepatitis B e antigen-negative chronic hepatitis B
Hadziyannis, S. J., & Vassilopoulos, D. (2001) · Hepatology · doi:10.1053/jhep.2001.27834 · Cited by 554
Donato, F., Boffetta, P., & Puoti, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980130)75:3<347::aid-ijc4>3.0.co;2-2 · Cited by 543
Fattovich, G., Giustina, G., Christensen, E., Pantalena, M., Zagni, I., Realdi, G., Schalm, S. W., & (Eurohep), T. E. C. A. O. V. H. (2000) · Gut · doi:10.1136/gut.46.3.420 · Cited by 515
Chronic hepatitis B: Update of recommendations† ‡
Lok, A. S. F., & McMahon, B. J. (2004) · Hepatology · doi:10.1002/hep.20110 · Cited by 500
Self-citationEpidemiology and Natural History of Hepatitis B
McMahon, B. J. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-915644 · Cited by 454
Self-citationSoriano, V., Sulkowski, M., Bergin, C., Hatzakis, A., Cacoub, P., Katlama, C., Cargnel, A., Mauss, S., Dieterich, D., Moreno, S., et al. (2002) · AIDS · doi:10.1097/00002030-200204120-00001 · Cited by 444
Lin, S.-M., Sheen, I.-S., Chien, R.-N., Chu, C.-M., & Liaw, Y.-F. (1999) · Hepatology · doi:10.1002/hep.510290312 · Cited by 444
Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus
McMahon, B. J., Holck, P., Bulkow, L., & Snowball, M. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00006 · Cited by 431
Self-citationSurvival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver
De Jongh, F. E., Janssen, H. L. A., De Man, R. A., Hop, W. C. J., Schalm, S. W., & Van Blankenstein, M. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91188-a · Cited by 418
Sánchez-Tapias, J. M., Costa, J., Mas, A., Bruguera, M., & Rodés, J. (2002) · Gastroenterology · doi:10.1053/gast.2002.37041 · Cited by 415
Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease
Sumi, H., Yokosuka, O., Seki, N., Arai, M., Imazeki, F., Kurihara, T., Kanda, T., Fukai, K., Kato, M., & Saisho, H. (2003) · Hepatology · doi:10.1053/jhep.2003.50036 · Cited by 403
Kumar, M., Sarin, S. K., Hissar, S., Pande, C., Sakhuja, P., Sharma, B. C., Chauhan, R., & Bose, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.075 · Cited by 401
Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.
Brunetto, M. R., Giarin, M. M., Oliveri, F., Chiaberge, E., Baldi, M., Alfarano, A., Serra, A., Saracco, G. M., Verme, G., & Will, H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4186 · Cited by 371
Fattovich, G., Giustina, G., Schalm, S. W., Hadziyannis, S., Sanchez-Tapias, J., Almasio, P., Christensen, E., Krogsgaard, K., Degos, F., De Moura, M. C., et al. (1995) · Hepatology · doi:10.1002/hep.1840210114 · Cited by 369
Chu, C., & Liaw, Y. (2007) · Hepatology · doi:10.1002/hep.21612 · Cited by 348
Liaw, Y.-F., Chu, C.-M., Su, I.-J., Huang, M.-J., Lin, D.-Y., & Chang-Chien, C.-S. (1983) · Gastroenterology · doi:10.1016/s0016-5085(83)80114-0 · Cited by 341
Brunetto, M. R., Oliveri, F., Coco, B., Leandro, G., Colombatto, P., Gorin, J. M., & Bonino, F. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00266-5 · Cited by 331
McMahon, B. J., Bulkow, L., Harpster, A., Snowball, M., Lanier, A., Sacco, F., Dunaway, E., & Williams, J. (2000) · Hepatology · doi:10.1053/jhep.2000.17914 · Cited by 327
Self-citationLok, A. S. F., Lai, C.-L., Wu, P.-C., Leung, E. K. Y., & Lam, T.-S. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90613-5 · Cited by 326
Chen, Y., Sheen, I. –., Chu, C., & Liaw, Y. (2002) · Gastroenterology · doi:10.1053/gast.2002.36026 · Cited by 325
Liaw, Y.-F., Sheen, I.-S., Chen, T.-J., Chu, C.-M., & Pao, C.-C. (1991) · Hepatology · doi:10.1002/hep.1840130403 · Cited by 294
The Natural History of Asymptomatic Hepatitis B Surface Antigen Carriers
de Franchis, R., Meucci, G., Vecchi, M., Tatarella, M., Colombo, M., Del Ninno, E., Rumi, M. G., Donato, M. F., & Ronchi, G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00006 · Cited by 292
Yu, M.-W., Hsu, F.-C., Sheen, I.-S., Chu, C.-M., Lin, D.-Y., Chen, C.-J., & Liaw, Y.-F. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009060 · Cited by 289
Spontaneous reactivation of chronic hepatitis B virus infection
Davis, G. L., Hoofnagle, J. H., & Waggoner, J. G. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90406-2 · Cited by 288
Chen, G., Lin, W., Shen, F., Iloeje, U. H., London, W. T., & Evans, A. A. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00647.x · Cited by 275
Hui, C., Leung, N., Yuen, S., Zhang, H., Leung, K., Lu, L., Cheung, S. K. F., Wong, W., & Lau, G. K. (2007) · Hepatology · doi:10.1002/hep.21724 · Cited by 266
Livingston, S. E., Simonetti, J. P., Bulkow, L. R., Homan, C. E., Snowball, M. M., Cagle, H. H., Negus, S. E., & McMahon, B. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.010 · Cited by 256
Self-citationFarci, P. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00331-3 · Cited by 245
Yuen, M.-F., Wong, D. K.-H., Sablon, E., Tse, E., Ng, I. O.-L., Yuan, H.-J., Siu, C.-W., Sander, T. J., Bourne, E. J., Hall, J. G., et al. (2004) · Hepatology · doi:10.1002/hep.20240 · Cited by 243
Liaw, Y.-F., Chen, Y.-C., Sheen, I.-S., Chien, R.-N., Yeh, C.-T., & Chu, C.-M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.011 · Cited by 243
Livingston, S. E., Simonetti, J. P., McMahon, B. J., Bulkow, L. R., Hurlburt, K. J., Homan, C. E., Snowball, M. M., Cagle, H. H., Williams, J. L., & Chulanov, V. P. (2007) · The Journal of Infectious Diseases · doi:10.1086/509894 · Cited by 241
Self-citationAcute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection
Lok, A. S. F., & Lai, C.-L. (1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90069-4 · Cited by 238
Bortolotti, F., Guido, M., Bartolacci, S., Cadrobbi, P., Crivellaro, C., Noventa, F., Morsica, G., Moriondo, M., & Gatta, A. (2006) · Hepatology · doi:10.1002/hep.21077 · Cited by 237
Chen, C., Hung, C., Lee, C., Hu, T., Wang, J., Wang, J., Lu, S., & Changchien, C. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.002 · Cited by 231
Fattovich, G., Giustina, G., Realdi, G., Corrocher, R., & Schalm, S. W. (1997) · Hepatology · doi:10.1002/hep.510260536 · Cited by 229
Grandjacques, C., Pradat, P., Stuyver, L., Chevallier, M., Chevallier, P., Pichoud, C., Maisonnas, M., Trépo, C., & Zoulim, F. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80279-2 · Cited by 214
Kirk, G. D., Lesi, O. A., Mendy, M., Akano, A. O., Sam, O., Goedert, J. J., Hainaut, P., Hall, A. J., Whittle, H., & Montesano, R. (2004) · Hepatology · doi:10.1002/hep.20027 · Cited by 210
Ahn, S. H., Park, Y. N., Park, J. Y., Chang, H.-Y., Lee, J. M., Shin, J. E., Han, K.-H., Park, C., Moon, Y. M., & Chon, C. Y. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.026 · Cited by 186
A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive chinese children
Lok, A. S. F., & Lai, C.-L. (1988) · Hepatology · doi:10.1002/hep.1840080527 · Cited by 177
Bortolotti, F., Cadrobbi, P., Crivellaro, C., Guido, M., Rugge, M., Noventa, F., Calzia, R., & Realdi, G. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90972-4 · Cited by 172
Kew, M., Yu, M.-C., Kedda, M., et al. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70233-6 · Cited by 157
Elimination of New Chronic Hepatitis B Virus Infections: Results of the Alaska Immunization Program
Harpaz, R., McMahon, B. J., Margolis, H. S., Shapiro, C. N., Havron, D., Carpenter, G., BULKOW, L. R., & Wainwright, R. B. (2000) · The Journal of Infectious Diseases · doi:10.1086/315259 · Cited by 157
Self-citationChang, M., Hsu, H., Hsu, H., Ni, Y., Chen, J.-S., & Chen, D. (1995) · Hepatology · doi:10.1002/hep.1840220508 · Cited by 149
Arase, Y., Ikeda, K., Suzuki, F., Suzuki, Y., Saitoh, S., Kobayashi, M., Akuta, N., Someya, T., Hosaka, T., Sezaki, H., et al. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.02.033 · Cited by 138
Zacharakis, G., Koskinas, J. S., Kotsiou, S., Papoutselis, M. K., Tzara, F., Vafeiadis, N., Archimandritis, A. J., & Papoutselis, K. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20434 · Cited by 107
Chu, C., Yeh, C., & Liaw, Y. (1999) · Gut · doi:10.1136/gut.45.4.613 · Cited by 102
Understudied populations with hepatitis C
Strader, D. B. (2002) · Hepatology · doi:10.1002/hep.1840360729 · Cited by 78
Lee, P., Chang, M., Lee, C., Hsu, H., Chen, J.-S., Chen, P., & Chen, D. (1990) · Hepatology · doi:10.1002/hep.1840120406 · Cited by 67
Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection
Hadziyannis, S. J., & Vassilopoulos, D. (2001) · Antiviral Research · doi:10.1016/s0166-3542(01)00173-5 · Cited by 50
Cited by
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Self-citationAASLD guidelines for treatment of chronic hepatitis B
Terrault, N. A., Bzowej, N. H., Chang, K., Hwang, J. P., Jonas, M. M., & Murad, M. H. (2016) · Hepatology · doi:10.1002/hep.28156 · Cited by 2,006
Hepatocellular carcinoma: a review
Balogh, J., Victor, D., Asham, E. H., Burroughs, S. G., Boktour, M., Saharia, A., Li, X., Ghobrial, M., & Monsour, H. (2016) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s61146 · Cited by 1,185
Hepatitis B: The virus and disease #
Liang, J. T. (2009) · Hepatology · doi:10.1002/hep.22881 · Cited by 1,061
Global Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & London, W. T. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.001 · Cited by 908
Metadata
- Authors
- McMahon, B. J.
- Venue
- Hepatology
- Published
- 2009-05
- Volume
- 49
- Issue
- Suppl. 5
- Pages
- S45-S55
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2142788779
- Cited by
- 876
- References
- 66
- FWCI
- 34.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.